| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Lessons learned from use of highly active antiretroviral therapy in Africa.
|
Clin Infect Dis
|
2005
|
4.96
|
|
2
|
Human immunodeficiency virus in correctional facilities: a review.
|
Clin Infect Dis
|
2002
|
3.27
|
|
3
|
Feasibility and acceptability of rapid HIV testing in jail.
|
AIDS Patient Care STDS
|
2007
|
2.52
|
|
4
|
It is time to implement routine, not risk-based, HIV testing.
|
Clin Infect Dis
|
2005
|
2.40
|
|
5
|
Natural history of human immunodeficiency virus disease in southern India.
|
Clin Infect Dis
|
2002
|
2.39
|
|
6
|
Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India.
|
J Acquir Immune Defic Syndr
|
2006
|
2.30
|
|
7
|
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.
|
J Acquir Immune Defic Syndr
|
2011
|
1.97
|
|
8
|
Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India.
|
J Acquir Immune Defic Syndr
|
2004
|
1.97
|
|
9
|
The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India.
|
Clin Infect Dis
|
2005
|
1.95
|
|
10
|
The importance of routine HIV testing in the incarcerated population: the Rhode Island experience.
|
AIDS Educ Prev
|
2002
|
1.91
|
|
11
|
A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
|
AIDS
|
2007
|
1.83
|
|
12
|
Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge.
|
J Health Care Poor Underserved
|
2008
|
1.81
|
|
13
|
Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
|
J Immunol
|
2002
|
1.76
|
|
14
|
Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study.
|
Clin Infect Dis
|
2006
|
1.72
|
|
15
|
Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries.
|
J Acquir Immune Defic Syndr
|
2002
|
1.71
|
|
16
|
Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world.
|
AIDS
|
2011
|
1.63
|
|
17
|
Adverse effects of highly active antiretroviral therapy in developing countries.
|
Clin Infect Dis
|
2007
|
1.56
|
|
18
|
The use of community-based modified directly observed therapy for the treatment of HIV-infected persons.
|
J Acquir Immune Defic Syndr
|
2005
|
1.46
|
|
19
|
Clinical profile of HIV in India.
|
Indian J Med Res
|
2005
|
1.41
|
|
20
|
A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy.
|
AIDS Read
|
2005
|
1.38
|
|
21
|
Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
|
AIDS
|
2007
|
1.34
|
|
22
|
Adherence to HIV treatment and care among previously homeless jail detainees.
|
AIDS Behav
|
2013
|
1.33
|
|
23
|
Apathy is associated with volume of the nucleus accumbens in patients infected with HIV.
|
J Neuropsychiatry Clin Neurosci
|
2005
|
1.29
|
|
24
|
The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India.
|
AIDS
|
2003
|
1.27
|
|
25
|
Unprotected sex with multiple partners: implications for HIV prevention among young men with a history of incarceration.
|
Sex Transm Dis
|
2006
|
1.26
|
|
26
|
A success story: HIV prevention for injection drug users in Rhode Island.
|
Subst Abuse Treat Prev Policy
|
2006
|
1.26
|
|
27
|
Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.
|
AIDS Patient Care STDS
|
2008
|
1.26
|
|
28
|
The impact of apathy and depression on quality of life in patients infected with HIV.
|
AIDS Patient Care STDS
|
2003
|
1.24
|
|
29
|
Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus.
|
J Neuropsychiatry Clin Neurosci
|
2005
|
1.18
|
|
30
|
Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings.
|
J Acquir Immune Defic Syndr
|
2004
|
1.13
|
|
31
|
Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.
|
J Acquir Immune Defic Syndr
|
2011
|
1.10
|
|
32
|
HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care.
|
Curr Opin Infect Dis
|
2013
|
1.07
|
|
33
|
A review of the case for hepatitis B vaccination of high-risk adults.
|
Am J Med
|
2003
|
1.06
|
|
34
|
Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment.
|
Sex Transm Dis
|
2002
|
1.04
|
|
35
|
Initial outcomes of an emergency department rapid HIV testing program in western Kenya.
|
AIDS Patient Care STDS
|
2007
|
1.03
|
|
36
|
Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail.
|
AIDS Behav
|
2013
|
1.02
|
|
37
|
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.
|
J Acquir Immune Defic Syndr
|
2011
|
1.02
|
|
38
|
Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings.
|
Am J Public Health
|
2014
|
0.99
|
|
39
|
Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1.
|
Clin Infect Dis
|
2002
|
0.97
|
|
40
|
Young incarcerated men's perceptions of and experiences with HIV testing.
|
Am J Public Health
|
2007
|
0.97
|
|
41
|
Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients.
|
AIDS
|
2005
|
0.95
|
|
42
|
Lessons learned from family-centred models of treatment for children living with HIV: current approaches and future directions.
|
J Int AIDS Soc
|
2010
|
0.95
|
|
43
|
HIV-positive and in jail: race, risk factors, and prior access to care.
|
AIDS Behav
|
2013
|
0.95
|
|
44
|
Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care.
|
J Acquir Immune Defic Syndr
|
2011
|
0.94
|
|
45
|
Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens.
|
HIV Clin Trials
|
2003
|
0.91
|
|
46
|
Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release.
|
AIDS Behav
|
2013
|
0.91
|
|
47
|
Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.
|
PLoS One
|
2013
|
0.91
|
|
48
|
Routine HIV testing among inpatients.
|
Arch Intern Med
|
2002
|
0.89
|
|
49
|
HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients.
|
AIDS
|
2002
|
0.89
|
|
50
|
HIV risk behavior before and after HIV counseling and testing in jail: a pilot study.
|
J Acquir Immune Defic Syndr
|
2010
|
0.88
|
|
51
|
Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2005
|
0.87
|
|
52
|
Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients.
|
J Int Assoc Physicians AIDS Care (Chic)
|
2011
|
0.85
|
|
53
|
Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.
|
PLoS One
|
2010
|
0.84
|
|
54
|
Short communication: new HIV infections at Southern New England academic institutions: implications for prevention.
|
AIDS Res Hum Retroviruses
|
2012
|
0.84
|
|
55
|
Changes in demographics and risk factors among persons living with HIV in an academic medical center from 2003-2007.
|
Med Health R I
|
2009
|
0.83
|
|
56
|
The intertwined epidemics of HIV infection, incarceration, and substance abuse: a call to action.
|
J Infect Dis
|
2011
|
0.83
|
|
57
|
Follow-up care among HIV-infected pregnant women in Mississippi.
|
J Womens Health (Larchmt)
|
2010
|
0.82
|
|
58
|
Racial/ethnic attitudes towards HIV testing in the primary care setting.
|
J Natl Med Assoc
|
2005
|
0.82
|
|
59
|
Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen.
|
Clin Infect Dis
|
2011
|
0.81
|
|
60
|
Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?
|
J Addict Med
|
2012
|
0.81
|
|
61
|
Monitoring HIV treatment in the developing world.
|
Lancet Infect Dis
|
2002
|
0.80
|
|
62
|
HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City.
|
AIDS Res Treat
|
2011
|
0.80
|
|
63
|
Community-based interventions for marginalized populations.
|
Clin Infect Dis
|
2004
|
0.80
|
|
64
|
Small reservoirs: jail screening for gonorrhea and Chlamydia in low prevalence areas.
|
J Correct Health Care
|
2009
|
0.79
|
|
65
|
Directly observed therapy (DOT) for individuals with HIV: successes and challenges.
|
MedGenMed
|
2003
|
0.79
|
|
66
|
HIV among marginalized populations in Rhode Island.
|
Med Health R I
|
2009
|
0.79
|
|
67
|
Clinical outcomes among HIV/tuberculosis-coinfected patients developing immune reconstitution inflammatory syndrome after HAART initiation in South India.
|
J Int Assoc Provid AIDS Care
|
2012
|
0.78
|
|
68
|
Routine HIV testing in jails is critical for the early diagnosis of HIV infection in men.
|
Clin Infect Dis
|
2008
|
0.78
|
|
69
|
Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.
|
AIDS Patient Care STDS
|
2004
|
0.78
|
|
70
|
Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence.
|
AIDS
|
2003
|
0.78
|
|
71
|
The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult.
|
Clin Infect Dis
|
2006
|
0.77
|
|
72
|
Editorial commentary: Hepatitis C virus testing and drug use in north america; is there more than meets the eye?
|
Clin Infect Dis
|
2013
|
0.77
|
|
73
|
Routine HIV testing in US prisons.
|
Lancet Infect Dis
|
2007
|
0.76
|
|
74
|
Directly observed therapy for HIV/tuberculosis co-infection.
|
Lancet Infect Dis
|
2004
|
0.76
|
|
75
|
Public health principles for the HIV epidemic.
|
N Engl J Med
|
2006
|
0.75
|
|
76
|
Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavir.
|
AIDS
|
2006
|
0.75
|
|
77
|
Outpatient parenteral antibiotic therapy in an academic practice in Rhode Island.
|
R I Med J (2013)
|
2014
|
0.75
|
|
78
|
The extraordinary hope of antiretroviral therapy in South Africa (even for patients with tuberculosis or kaposi sarcoma!).
|
J Infect Dis
|
2004
|
0.75
|
|
79
|
Screening for HIV.
|
Ann Intern Med
|
2005
|
0.75
|
|
80
|
HIV testing practices among New England college health centers.
|
AIDS Res Ther
|
2013
|
0.75
|
|
81
|
Routine, not risk-based, human immunodeficiency virus testing is the way to go.
|
J Infect Dis
|
2003
|
0.75
|
|
82
|
Risk factors for non-communicable diseases in prison populations.
|
Lancet
|
2012
|
0.75
|
|
83
|
HIV counseling and testing among injection drug users needs to continue.
|
Am J Public Health
|
2007
|
0.75
|
|
84
|
Point of view: the rapid spread of HIV among minority communities in the United States: a call to action.
|
Med Health R I
|
2003
|
0.75
|
|
85
|
Antiretroviral rounds. A communication conundrum.
|
AIDS Clin Care
|
2005
|
0.75
|
|
86
|
Spontaneous perforation of the terminal ileum in an AIDS patient on highly active antiretroviral therapy with disseminated non-tuberculous mycobacterial infection.
|
Int J Infect Dis
|
2008
|
0.75
|
|
87
|
Confronting the clinical uncertainty regarding syphilis.
|
AIDS Clin Care
|
2003
|
0.75
|